Emily Moore
Family · Arkadelphia, ARNPI 1730579921
Payments from drug & device makers
Across 175 payments — averaging $13.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Lilly USA, LLC$323
- Abbott$269
- Dexcom, Inc.$265
- Amgen$145
- Pfizer$128
- plus $735 from 20 others
What the payments were for
- Food & beverage$2,326100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $461 |
| Lilly USA, LLC | 31 | $323 |
| Abbott | 15 | $269 |
| Dexcom, Inc. | 15 | $265 |
| Amgen | 10 | $145 |
| Pfizer | 8 | $128 |
| AstraZeneca | 6 | $103 |
| Astellas Pharma US Inc | 5 | $100 |
| Novo Nordisk | 5 | $66 |
| Exact Sciences | 4 | $63 |
| Novartis | 3 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $47 |
| Nestle Healthcare Nutrition Inc. | 3 | $41 |
| Abiomed | 1 | $39 |
| Boehringer Ingelheim | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Merck | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Bayer | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$2,326 in reported general payments places this provider in the 80th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $51,053 |
| EliquisApixaban | 36 | $26,091 |
| JardianceEmpagliflozin | 24 | $21,568 |
| MounjaroTirzepatide | 17 | $18,278 |
| JanuviaSitagliptin Phosphate | 15 | $10,352 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $8,163 |
| XareltoRivaroxaban | 12 | $8,049 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $6,588 |
| NexletolBempedoic Acid | 11 | $4,312 |
| Varenicline Tartrate | 18 | $3,636 |
| PremarinEstrogens, Conjugated | 13 | $2,998 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $2,070 |
| Pregabalin | 20 | $1,820 |
| Gabapentin | 156 | $1,660 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 44 | $1,620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $18 | $51,05363 claims |
| PfizerEliquis, Premarin | $128 | $29,09049 claims |
| Boehringer IngelheimJardiance | $28 | $21,56824 claims |
| Lilly USA, LLCMounjaro | $323 | $18,27817 claims |
| MerckJanuvia | $25 | $10,35215 claims |
| AstraZenecaSymbicort | $103 | $8,16328 claims |
| Esperion Therapeutics, Inc.Nexletol | $16 | $4,31211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,103 family providers in Arkansas.
Other family in Arkadelphia
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.